{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:16Z","timestamp":1772119216799,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08194-1","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:57:03Z","timestamp":1763384223000},"page":"2333-2340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study)"],"prefix":"10.1007","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-0979","authenticated-orcid":false,"given":"Fuminori","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8140-4565","authenticated-orcid":false,"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Itani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Onuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Egawa-Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3459-7485","authenticated-orcid":false,"given":"Takashi","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3115-7997","authenticated-orcid":false,"given":"Kimihiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"8194_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.critrevonc.2018.10.005","volume":"133","author":"A Gadducci","year":"2019","unstructured":"Gadducci A, Guerrieri ME, Cosio S (2019) Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a challenging question for gynecologic oncologists. Crit Rev Oncol Hematol 133:92\u201398. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.10.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"8194_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","volume":"9","author":"A Hackethal","year":"2008","unstructured":"Hackethal A, Brueggmann D, Bohlmann MK et al (2008) Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. Lancet Oncol 9:1173\u20131180. https:\/\/doi.org\/10.1016\/S1470-2045(08)70306-1","journal-title":"Lancet Oncol"},{"key":"8194_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12885-019-5393-y","volume":"19","author":"C Li","year":"2019","unstructured":"Li C, Zhang Q, Zhang S et al (2019) Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review. BMC Cancer 19:217. https:\/\/doi.org\/10.1186\/s12885-019-5393-y","journal-title":"BMC Cancer"},{"key":"8194_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"8194_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jog.12936","volume":"42","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Kajiyama H, Utsumi F et al (2016) Radiotherapy for persistent malignant transformation from mature cystic teratoma of the ovary. J Obstet Gynaecol Res 42:584\u2013588. https:\/\/doi.org\/10.1111\/jog.12936","journal-title":"J Obstet Gynaecol Res"},{"key":"8194_CR6","doi-asserted-by":"publisher","first-page":"e24726","DOI":"10.1097\/MD.0000000000024726","volume":"100","author":"L Qin","year":"2021","unstructured":"Qin L, Zhao T, Liu X et al (2021) Malignant transformation arising from mature ovarian cystic teratoma: a case series. Medicine (Baltimore) 100:e24726. https:\/\/doi.org\/10.1097\/MD.0000000000024726","journal-title":"Medicine (Baltimore)"},{"key":"8194_CR7","doi-asserted-by":"publisher","first-page":"842703","DOI":"10.3389\/fonc.2022.842703","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Qin M, Shan Y et al (2022) 30-year experience with 22 cases of malignant transformation arising from ovarian mature cystic teratoma: a rare disease. Front Oncol 12:842703. https:\/\/doi.org\/10.3389\/fonc.2022.842703","journal-title":"Front Oncol"},{"key":"8194_CR8","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.3802\/jgo.2017.28.e69","volume":"28","author":"AJ Chiang","year":"2017","unstructured":"Chiang AJ, Chen MY, Weng CS et al (2017) Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study. J Gynecol Oncol 28:e69. https:\/\/doi.org\/10.3802\/jgo.2017.28.e69","journal-title":"J Gynecol Oncol"},{"key":"8194_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0929-6646(08)60202-8","volume":"107","author":"RJ Chen","year":"2008","unstructured":"Chen RJ, Chen KY, Chang TC, Sheu BC, Chow SN, Huang SC (2008) Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary. J Formos Med Assoc 107:857\u2013868. https:\/\/doi.org\/10.1016\/S0929-6646(08)60202-8","journal-title":"J Formos Med Assoc"},{"key":"8194_CR10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/IGC.0000000000001375","volume":"28","author":"M Akazawa","year":"2018","unstructured":"Akazawa M, Onjo S (2018) Malignant transformation of mature cystic teratoma: is squamous cell carcinoma different from the other types of neoplasm? Int J Gynecol Cancer 28:1650\u20131656. https:\/\/doi.org\/10.1097\/IGC.0000000000001375","journal-title":"Int J Gynecol Cancer"},{"key":"8194_CR11","doi-asserted-by":"publisher","first-page":"100632","DOI":"10.1016\/j.gore.2020.100632","volume":"34","author":"M Fukase","year":"2020","unstructured":"Fukase M, Ohta T, Watanabe N et al (2020) Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: successful treatment with carboplatin, paclitaxel, and bevacizumab. Gynecol Oncol Rep 34:100632. https:\/\/doi.org\/10.1016\/j.gore.2020.100632","journal-title":"Gynecol Oncol Rep"},{"key":"8194_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13048-020-00675-y","volume":"13","author":"C Zhang","year":"2020","unstructured":"Zhang C, Ma T (2020) Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database. J Ovarian Res 13:75. https:\/\/doi.org\/10.1186\/s13048-020-00675-y","journal-title":"J Ovarian Res"},{"key":"8194_CR13","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.21037\/apm-20-2429","volume":"10","author":"X Li","year":"2021","unstructured":"Li X, Tang X, Zhuo W (2021) Malignant transformation of ovarian teratoma responded well to immunotherapy after failed chemotherapy: a case report. Ann Palliat Med 10:8499\u20138505. https:\/\/doi.org\/10.21037\/apm-20-2429","journal-title":"Ann Palliat Med"},{"key":"8194_CR14","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1038\/s41388-020-1237-0","volume":"39","author":"R Tamura","year":"2020","unstructured":"Tamura R, Yoshihara K, Nakaoka H et al (2020) XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary. Oncogene 39:3541\u20133554. https:\/\/doi.org\/10.1038\/s41388-020-1237-0","journal-title":"Oncogene"},{"key":"8194_CR15","unstructured":"Japan Registry of Clinical Trials (2023) A single-arm open-label phase II trial to assess the efficacy and safety of Pembrolizumab for unresectable advanced or recurrent ovarian squamous cell carcinoma (JGOG3029). jRCT2031220701. https:\/\/jrct.mhlw.go.jp\/latest-detail\/jRCT2031220701. Accessed May 25, 2025."}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08194-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:07:37Z","timestamp":1765804057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08194-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8194"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08194-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6777190\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to correction regarding space between two different lines on Table 6.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from each participating institution and the Nara Prefecture General Medical Center ethics committee (H25-167) on June 19, 2013. This study was conducted in accordance with the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}